An overview and management of osteoporosis
- PMID: 28293453
- PMCID: PMC5335887
- DOI: 10.5152/eurjrheum.2016.048
An overview and management of osteoporosis
Abstract
Osteoporosis -related to various factors including menopause and aging- is the most common chronic metabolic bone disease, which is characterized by increased bone fragility. Although it is seen in all age groups, gender, and races, it is more common in Caucasians (white race), older people, and women. With an aging population and longer life span, osteoporosis is increasingly becoming a global epidemic. Currently, it has been estimated that more than 200 million people are suffering from osteoporosis. According to recent statistics from the International Osteoporosis Foundation, worldwide, 1 in 3 women over the age of 50 years and 1 in 5 men will experience osteoporotic fractures in their lifetime. Every fracture is a sign of another impending one. Osteoporosis has no clinical manifestations until there is a fracture. Fractures cause important morbidity; in men, in particular, they can cause mortality. Moreover, osteoporosis results in a decreased quality of life, increased disability-adjusted life span, and big financial burden to health insurance systems of countries that are responsible for the care of such patients. With an early diagnosis of this disease before fractures occur and by assessing the bone mineral density and with early treatment, osteoporosis can be prevented. Therefore, increasing awareness among doctors, which, in turn, facilitates increase awareness of the normal populace, will be effective in preventing this epidemic.
Keywords: Osteoporosis; bone mineral density; fracture risk; osteoporosis management.
Conflict of interest statement
Conflict of Interest: No conflict of interest was declared by the authors.
Figures
Similar articles
-
Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Postgrad Med. 2010. PMID: 20107292 Review.
-
Epidemiology of hip fractures.Bone. 1996 Jan;18(1 Suppl):57S-63S. doi: 10.1016/8756-3282(95)00381-9. Bone. 1996. PMID: 8717549 Review.
-
Major osteoporotic fragility fractures: Risk factor updates and societal impact.World J Orthop. 2016 Mar 18;7(3):171-81. doi: 10.5312/wjo.v7.i3.171. eCollection 2016 Mar 18. World J Orthop. 2016. PMID: 27004165 Free PMC article. Review.
-
Epidemiology and economic burden of osteoporosis in Switzerland.Arch Osteoporos. 2014;9:187. doi: 10.1007/s11657-014-0187-y. Epub 2014 Jun 27. Arch Osteoporos. 2014. PMID: 24970672 Review.
-
The worldwide problem of osteoporosis: insights afforded by epidemiology.Bone. 1995 Nov;17(5 Suppl):505S-511S. doi: 10.1016/8756-3282(95)00258-4. Bone. 1995. PMID: 8573428 Review.
Cited by
-
Dietary Behaviors That Place Young Adults at Risk for Future Osteoporosis.Nutrients. 2020 Jun 17;12(6):1800. doi: 10.3390/nu12061800. Nutrients. 2020. PMID: 32560378 Free PMC article.
-
LncRNA DANCR and miR-320a suppressed osteogenic differentiation in osteoporosis by directly inhibiting the Wnt/β-catenin signaling pathway.Exp Mol Med. 2020 Aug;52(8):1310-1325. doi: 10.1038/s12276-020-0475-0. Epub 2020 Aug 11. Exp Mol Med. 2020. PMID: 32778797 Free PMC article.
-
Antioxidant, Anti-Inflammatory, Anti-Diabetic, and Pro-Osteogenic Activities of Polyphenols for the Treatment of Two Different Chronic Diseases: Type 2 Diabetes Mellitus and Osteoporosis.Biomolecules. 2024 Jul 11;14(7):836. doi: 10.3390/biom14070836. Biomolecules. 2024. PMID: 39062550 Free PMC article. Review.
-
The associations between short-term exposure to ambient particulate matter and hospitalizations for osteoporotic fracture in Hangzhou: a time-stratified case-crossover study.Arch Osteoporos. 2022 Dec 5;18(1):4. doi: 10.1007/s11657-022-01192-9. Arch Osteoporos. 2022. PMID: 36469172
-
Poly(lactic-co-glycolic acid)-based composite bone-substitute materials.Bioact Mater. 2020 Aug 29;6(2):346-360. doi: 10.1016/j.bioactmat.2020.08.016. eCollection 2021 Feb. Bioact Mater. 2020. PMID: 32954053 Free PMC article. Review.
References
-
- NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785–95. - PubMed
-
- Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25:2359–81. https://doi.org/10.1007/s00198-014-2794-2. - DOI - PMC - PubMed
-
- Cooper C, Campion G, Melton LJ., 3rd Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285–9. https://doi.org/10.1007/BF01623184. - DOI - PubMed
-
- Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone. 2006;38(Suppl 1):S4–9. https://doi.org/10.1016/j.bone.2005.11.024. - DOI - PubMed
-
- Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014;29:2520–6. https://doi.org/10.1002/jbmr.2269. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical